These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1167 related items for PubMed ID: 14639511
1. [Utility of quetiapine in tardive dyskinesia]. Navarro Pacheco BV, Montejo González AL, Martín Carrasco M. Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511 [Abstract] [Full Text] [Related]
2. Using antipsychotic agents in older patients. Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733 [Abstract] [Full Text] [Related]
3. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM, Yu SC, Lin CC. J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [Abstract] [Full Text] [Related]
4. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia. Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP. J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258 [Abstract] [Full Text] [Related]
5. [Quetiapine treatment of risperidone-related tardive dyskinesia. A case report]. Alcantara Lapaz AG, García Fernández L, Martínez MJ. Actas Esp Psiquiatr; 2003 May; 31(5):306. PubMed ID: 14557956 [No Abstract] [Full Text] [Related]
6. Treatment of generalized tardive dystonia with clozapine. Aukst-Margetić B, Margetić B. Psychiatr Danub; 2008 Sep; 20(3):329-31. PubMed ID: 18827758 [Abstract] [Full Text] [Related]
7. Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone. Nelson MW, Reynolds RR, Kelly DL, Conley RR. Clin Neuropharmacol; 2003 Sep; 26(6):297-8. PubMed ID: 14646608 [Abstract] [Full Text] [Related]
8. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease]. Giménez-Roldán S, Navarro E, Mateo D. Rev Neurol; 2003 Sep; 36(5):401-4. PubMed ID: 12640589 [Abstract] [Full Text] [Related]
13. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]. Khaldi S, Kornreich C, Choubani Z, Gourevitch R. Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460 [Abstract] [Full Text] [Related]
14. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature. Peritogiannis V, Tsouli S. J Psychopharmacol; 2010 Jul; 24(7):1121-5. PubMed ID: 19395427 [Abstract] [Full Text] [Related]
15. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia. Bishnoi M, Kumar A, Chopra K, Kulkarni SK. Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557 [Abstract] [Full Text] [Related]
16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
17. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial. Byerly MJ, Nakonezny PA, Rush AJ. Psychiatry Res; 2008 May 30; 159(1-2):115-20. PubMed ID: 18295343 [Abstract] [Full Text] [Related]